Lawsuit Overview
May 3, 2013 (Shareholders Foundation) - An investor, who holds NYSEAMEX:PBTH shares, filed a lawsuit in effort to stop the proposed takeover of PROLOR Biotech Inc by OPKO Health, Inc.to acquire for approximately $7.00 per NYSEAMEX:PBTH share. The plaintiff says that the defendants allegedly breached their fiduciary duties owed to NYSEAMEX:PBTH stockholder by agreeing to sell the comp...
You must register (for free) or login to view the entire case.